BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 8892857)

  • 1. Tumor necrosis factor alpha inhibits entry of human immunodeficiency virus type 1 into primary human macrophages: a selective role for the 75-kilodalton receptor.
    Herbein G; Montaner LJ; Gordon S
    J Virol; 1996 Nov; 70(11):7388-97. PubMed ID: 8892857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 55- and 75-kilodalton tumor necrosis factor receptors mediate distinct actions in regard to human immunodeficiency virus type 1 replication in primary human macrophages.
    Herbein G; Gordon S
    J Virol; 1997 May; 71(5):4150-6. PubMed ID: 9094699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-10 inhibits initial reverse transcription of human immunodeficiency virus type 1 and mediates a virostatic latent state in primary blood-derived human macrophages in vitro.
    Montaner LJ; Griffin P; Gordon S
    J Gen Virol; 1994 Dec; 75 ( Pt 12)():3393-400. PubMed ID: 7527834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 envelope glycoprotein gp120 down-regulates CD4 expression in primary human macrophages through induction of endogenous tumour necrosis factor-alpha.
    Karsten V; Gordon S; Kirn A; Herbein G
    Immunology; 1996 May; 88(1):55-60. PubMed ID: 8707350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-10 enhances tumor necrosis factor-alpha activation of HIV-1 transcription in latently infected T cells.
    Rabbi MF; Finnegan A; Al-Harthi L; Song S; Roebuck KA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(4):321-31. PubMed ID: 9833740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 induces tumour necrosis factor and IL-1 gene expression in primary human macrophages independent of productive infection.
    Herbein G; Keshav S; Collin M; Montaner LJ; Gordon S
    Clin Exp Immunol; 1994 Mar; 95(3):442-9. PubMed ID: 7511077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipopolysaccharide (LPS) down-regulates CD4 expression in primary human macrophages through induction of endogenous tumour necrosis factor (TNF) and IL-1 beta.
    Herbein G; Doyle AG; Montaner LJ; Gordon S
    Clin Exp Immunol; 1995 Nov; 102(2):430-7. PubMed ID: 7586702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human immunodeficiency virus replication in differentiating monocytes by interleukin 10 occurs in parallel with inhibition of cellular RNA expression.
    Naif HM; Chang J; Ho-Shon M; Li S; Cunningham AL
    AIDS Res Hum Retroviruses; 1996 Sep; 12(13):1237-45. PubMed ID: 8870845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymocyte-thymic epithelial cell interaction leads to high-level replication of human immunodeficiency virus exclusively in mature CD4(+) CD8(-) CD3(+) thymocytes: a critical role for tumor necrosis factor and interleukin-7.
    Chêne L; Nugeyre MT; Guillemard E; Moulian N; Barré-Sinoussi F; Israël N
    J Virol; 1999 Sep; 73(9):7533-42. PubMed ID: 10438843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased human immunodeficiency virus (HIV) expression in chronically infected U937 cells upon in vitro differentiation by hydroxyvitamin D3: roles of interferon and tumor necrosis factor in regulation of HIV production.
    Locardi C; Petrini C; Boccoli G; Testa U; Dieffenbach C; Buttò S; Belardelli F
    J Virol; 1990 Dec; 64(12):5874-82. PubMed ID: 1700829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulation of membrane-bound tumor necrosis factor-alpha and tumor necrosis factor receptors on mononuclear cells in human immunodeficiency virus type 1 infection: low percentage of p75-tumor necrosis factor receptor positive cells in patients with advanced disease and high viral load.
    Hestdal K; Aukrust P; Müller F; Lien E; Bjerkeli V; Espevik T; Frøland SS
    Blood; 1997 Oct; 90(7):2670-9. PubMed ID: 9326234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replication of human immunodeficiency virus-1 in primary human T cells is dependent on the autocrine secretion of tumor necrosis factor through the control of nuclear factor-kappa B activation.
    Muñoz-Fernández MA; Navarro J; Garcia A; Punzón C; Fernández-Cruz E; Fresno M
    J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 1):838-45. PubMed ID: 9438495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic stimulatory effects of tumour necrosis factor alpha and interferon gamma on replication of human immunodeficiency virus type 1 and on apoptosis of HIV-1-infected host cells.
    Han X; Becker K; Degen HJ; Jablonowski H; Strohmeyer G
    Eur J Clin Invest; 1996 Apr; 26(4):286-92. PubMed ID: 8732485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble tumor necrosis factor receptors inhibit phorbol myristate acetate and cytokine-induced HIV-1 expression chronically infected U1 cells.
    Granowitz EV; Saget BM; Angel JB; Wang MZ; Wang A; Dinarello CA; Skolnik PR
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(5):430-7. PubMed ID: 8605587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble tumor necrosis factor receptor: inhibition of human immunodeficiency virus activation.
    Howard OM; Clouse KA; Smith C; Goodwin RG; Farrar WL
    Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2335-9. PubMed ID: 7681592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium valproate, an anticonvulsant drug, stimulates human immunodeficiency virus type 1 replication independently of glutathione levels.
    Moog C; Kuntz-Simon G; Caussin-Schwemling C; Obert G
    J Gen Virol; 1996 Sep; 77 ( Pt 9)():1993-9. PubMed ID: 8810995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infection of human macrophages with an endogenous tumour necrosis factor-alpha (TNF-alpha)-independent human immunodeficiency virus type 1 isolate is unresponsive to the TNF-alpha synthesis inhibitor RP 55778.
    Le Naour R; Clayette P; Henin Y; Mabondzo A; Raoul H; Bousseau A; Dormont D
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1379-88. PubMed ID: 7515938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1.
    Granowitz EV; Saget BM; Wang MZ; Dinarello CA; Skolnik PR
    Mol Med; 1995 Sep; 1(6):667-77. PubMed ID: 8529133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective regulation of human immunodeficiency virus-infected CD4(+) lymphocytes by a synthetic immunomodulator leads to potent virus suppression in vitro and in hu-PBL-SCID mice.
    Bahr GM; Darcissac EC; Castéran N; Amiel C; Cocude C; Truong MJ; Dewulf J; Capron A; Mouton Y
    J Virol; 2001 Aug; 75(15):6941-52. PubMed ID: 11435574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists.
    Mhashilkar AM; Biswas DK; LaVecchio J; Pardee AB; Marasco WA
    J Virol; 1997 Sep; 71(9):6486-94. PubMed ID: 9261367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.